Skip to main content
CLOSE
MENU
TAIYO HOLDINGS CO., LTD.
Investor Relations
IR News
IR News
サブ-ナビゲーション
News Release
About Us
Group Companies
Business Domain
Products
Sustainability
Investor Relations
現在位置:
IR News
Management Policy
Corporate Governance
Disclosure Policy
IR Library
IR Calendar
Performance Overview
Financial Highlights
Return to Shareholders
Share Information
Outside Evaluations, etc.
Disclaimer
Our Challenges
Contact Us
Glossary
Terms of Use
About Personal Information
Social Media Policy
Cookie Policy
Cookie Preferences
IR News
2025/10/2
Beyond Imagination 2030 Medium-term Management Plan(with transcript)
（2,910KB）
2025/8/29
Annual Securities Report For the 79th business term (April 1, 2024 to March 31, 2025)
（3,549KB）
2025/8/28
Notice Regarding the Formulation of the Medium-term Management Plan
（1,114KB）
2025/8/20
Notice Regarding Completion of Payment for New Shares under Stock Compensation Plan
（99KB）
2025/8/15
【Delayed】(Addition) Additional explanation to the “Notice Regarding the Determination of the Issue Price, etc. for the Issuance of New Shares as Stock Compensation Plan”
（126KB）
2025/8/12
Notice Regarding the Determination of the Issue Price, etc. for the Issuance of New Shares as Stock Compensation Plan
（95KB）
2025/8/1
Notice Regarding the Issuance of New Shares as Stock Compensation Plan
（171KB）
2025/8/1
Notice Regarding Personnel Changes
（139KB）
2025/8/1
Notice Regarding Changes in the Responsibilities of the Board Director
（143KB）
2025/8/1
Notice Regarding “2030 Committee Interim Report”
（928KB）
2025/8/1
Consolidated Financial Result Digest FY2026/3 1Q (Fiscal Year Ended March 31, 2026)
（846KB）
2025/8/1
Notice of Revised the First-half and Full-year Earnings Forecasts for the Fiscal Year Ended March 31, 2026
（332KB）
2025/8/1
Consolidated Financial Results for the First Three Months of the Fiscal Year Ended March 31, 2026
（209KB）
2025/7/11
【Delayed】Notice Regarding Completion of Payment for New Shares as Stock Compensation Plan and Partial Forfeiture of Rights Granted to Allottees
（141KB）
2025/7/3
【Full】Notice Regarding Initiatives Following the Transition to a New Management Structure
（66KB）
2025/7/1
【Summary】Notice Regarding Initiatives Following the Transition to a New Management Structure
（131KB）
2025/6/25
Notice Regarding the Issuance of New Shares as Stock Compensation Plan
（240KB）
2025/6/23
Matters Concerning Controlling Shareholders, Etc.
（160KB）
2025/6/23
(Corrections) Partial Corrections to the “Notice Regarding Reductions in Amounts of Capital Legal Reserve and Retained Legal Reserve”
（135KB）
2025/6/23
Notice Regarding Personnel Changes
（147KB）
2025/6/23
Notice Regarding Chairman of the Board of Directors
（125KB）
2025/6/23
Notice Regarding Responsibilities of Board Directors
（131KB）
2025/6/23
Notice Regarding Changes in Representative Directors
（119KB）
2025/6/21
Notice of Resolutions at 79th Ordinary General Shareholders’ Meeting
（170KB）
2025/6/21
【Full】Notice Regarding the Details of a “2030 Committee”
（61KB）
2025/6/16
The Opinion Statement Regarding Shareholder Proposals and Company Proposals
（51KB）
2025/6/12
【Summary】Notice Regarding the Details of a “2030 Committee”
（117KB）
2025/6/3
Establishment of a “2030 Committee”
（297KB）
2025/5/29
【Republish】Supplementary Briefing Material of the Opinion of Taiyo Holdings’ Board of Directors on the Shareholder Proposals
（469KB）
2025/5/29
NOTICE OF 79TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
（274KB）
2025/5/28
Notice Regarding Reports in the Media
（83KB）
2025/5/28
Notice Regarding the Establishment of a “2030 Committee”
（35KB）
2025/5/22
Supplementary Briefing Material of the Opinion of Taiyo Holdings’ Board of Directors on the Shareholder Proposals
（469KB）
2025/5/22
Notice of the Opinion of Taiyo Holdings’ Board of Directors on the Shareholder Proposals
（78KB）
2025/5/16
Notice of the Opinion of Taiyo Holdings’ Board of Directors on the Shareholder Proposals
（120KB）
2025/5/16
Notice of the Candidates for Board Directors
（100KB）
2025/5/16
Notice Regarding Reductions in Amounts of Capital Legal Reserve and Retained Legal Reserve
（117KB）
2025/5/12
Notice Regarding Dividends of Surplus
（125KB）
2025/5/8
Notice Regarding the Receipt of Shareholder Proposals
（113KB）
2025/4/30
Notice Regarding Personnel Changes
（101KB）
2025/4/30
Consolidated Financial Result Digest FY2025/3 4Q (Fiscal Year Ended March 31, 2025)
（749KB）
2025/4/30
Notice Regarding Recognition of Extraordinary Losses on Non-consolidated Financial Statements
（104KB）
2025/4/30
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025
（858KB）
2025/4/2
Notice Concerning Change of Major Shareholder
（124KB）
2025/3/24
Notice Regarding Change in Shareholder Return Policy
（152KB）
2025/3/24
Notice of Revised Full-year Earnings Forecasts, Recognition of Extraordinary Losses, and Revised Dividend Forecast (Dividend Increase)
（161KB）
2025/3/12
Notice Regarding Personnel Changes
（104KB）
2025/3/12
Notice Regarding Changes in the Responsibilities of the Board Directors
（109KB）
2025/2/28
Green loan report（borrowed on January 31, 2024）
（402KB）
2025/2/5
Consolidated Financial Result Digest FY2025/3 Q3 (Fiscal Year Ended March 31, 2025)
（699KB）
2025/2/5
Notice of Revised Full-year Earnings Forecasts for the Fiscal Year Ended March 31, 2025
（110KB）
2025/2/5
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ended March 31, 2025
（277KB）
2025/1/31
Integrated Report 2024
（10,669KB）
2025/1/31
Green loan report（borrowed on August 31, 2023）
（101KB）
2025/1/7
Notice Regarding Reports in the Media
2024/11/6
Notice Regarding Extension of Trust Term and an Additional Financial Contribution to the ESOP Trust
（109KB）
2024/11/6
Consolidated Financial Result Digest FY2025/3 2Q (Fiscal Year Ended March 31, 2025)
（287KB）
2024/11/6
Notice of Revised Full-year Earnings Forecasts for the Fiscal Year Ended March 31, 2025
（110KB）
2024/11/6
Consolidated Financial Results for the Six Months of the Fiscal Year Ended March 31, 2025
（226KB）
2024/9/17
Notice Regarding Personnel Changes
（93KB）
2024/9/17
Notice Regarding an Additional Financial Contribution to the ESOP Trust
（107KB）
2024/9/5
Annual Securities Report For the 78th business term (April 1, 2023 to March 31, 2024)
（3,315KB）
2024/8/1
Consolidated Financial Result Digest FY2025/3 Q1 (Fiscal Year Ended March 31, 2025)
（611KB）
2024/8/1
Notice of Revised the First-half and Full-year Earnings Forecasts for the Fiscal Year Ended March 31, 2025
（131KB）
2024/8/1
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2025
（119KB）
2024/7/9
Notice Regarding Completion of Payment for New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
（131KB）
2024/6/27
[Delayed]Notice Regarding Issuance of New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
（169KB）
2024/6/20
Notice Regarding Personnel Changes
（94KB）
2024/6/17
Matters Concerning Controlling Shareholders, Etc.
（121KB）
2024/6/17
Notice Regarding Personnel Changes
（96KB）
2024/6/17
Notice Regarding Chairman of the Board of Directors
（94KB）
2024/6/17
Notice Regarding Responsibilities of Board Directors
（102KB）
2024/6/15
Notice of resolutions at 78th Ordinary General Shareholders’ Meeting
（96KB）
2024/6/14
Notice Regarding Launch of “MADOPAR® Combination Tablets L50” for a Treatment of Parkinsonism
（142KB）
2024/6/13
[Delayed]Notice Regarding Partial Amendment of the Articles of Incorporation
（175KB）
2024/6/13
[Delayed]Notice Regarding Company’s Propositions For 78th Ordinary General Shareholders’ Meeting
（242KB）
2024/5/23
NOTICE OF 78TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
（346KB）
2024/5/13
Notice Regarding Introduction of Post Issuance-Type Restricted Stock Granting Plan for Executive Officers, Etc.
（174KB）
2024/5/13
Notice Regarding the Change of the Candidates for Board Directors
（100KB）
2024/5/1
Notice Regarding Personnel Changes
（103KB）
2024/5/1
Consolidated Financial Result Digest FY2024/3 Q4 (Fiscal Year Ended March 31, 2024)
（755KB）
2024/5/1
Notice Regarding Recognition of Extraordinary Losses
（93KB）
2024/5/1
Notice regarding dividends from surplus
（122KB）
2024/5/1
Consolidated Financial Results for the Fiscal Year Ended March 31, 2024
（279KB）
2024/4/10
Notice Regarding Change of Major Shareholder
（114KB）
2024/4/1
Notice regarding acquisition and acquisition completion of Treasury Stock
（116KB）
2024/3/21
Integrated Report 2023
（8,454KB）
2024/3/15
Notice of the Candidates for Board Directors
（91KB）
2024/3/15
Notice Regarding Personnel Changes
（90KB）
2024/3/8
Notice regarding acquisition of treasury stock
（115KB）
2024/2/15
Notice Regarding Receiving Manufacturing and Marketing Approval for Additional Formulation, Madopar® L50 Combination Tablets for the Treatment of Parkinsonism
（124KB）
2024/2/9
Notice regarding acquisition of treasury stock
（115KB）
2024/2/2
Consolidated Financial Result Digest FY2024/3 Q3 (Fiscal Year Ended March 31, 2024)
（419KB）
2024/2/2
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ended March 31, 2024
（162KB）
2024/1/31
Notice Regarding Green Loan Agreement
（873KB）
2024/1/10
Notice regarding acquisition of treasury stock
（115KB）
2023/12/8
Notice regarding acquisition of treasury stock
（115KB）
2023/11/10
Notice regarding acquisition of treasury stock
（115KB）
2023/11/6
Notice of Partial Correction to “Consolidated Financial Result Digest FY2024 Q1 (Fiscal Year Ended March 31, 2024)”
（751KB）
2023/11/6
Consolidated Financial Result Digest FY2024/3 Q2 (Fiscal Year Ended March 31, 2024)
（685KB）
2023/11/6
Notice of Differences between Earnings Forecasts and Financial Results for the First Six Months of the Fiscal Year Ended March 2024, (and Revised Earnings Forecasts) for the Fiscal Year Ended March 2024
（105KB）
2023/11/6
Consolidated Financial Results for the First Six Months of the Fiscal Year Ended March 31, 2024
（88KB）
2023/10/10
Notice regarding acquisition of treasury stock
（115KB）
2023/9/20
Annual Securities Report For the 77th business term (April 1, 2022 to March 31, 2023)
（2,060KB）
2023/9/14
Notice regarding personnel changes
（83KB）
2023/9/14
Notice regarding change in responsibility of the director
（84KB）
2023/9/14
Notice Regarding Transition to Company with Audit & Supervisory Committee
（87KB）
2023/9/8
Notice regarding acquisition of treasury stock
（117KB）
2023/8/31
Notice Regarding Green Loan Agreement
（465KB）
2023/8/10
Notice regarding acquisition of treasury stock
（116KB）
2023/8/10
Taiyo Holdings Selected as a Constituent of the JPX Nikkei Index 400 for the First Time
（130KB）
2023/8/1
Consolidated Financial Result Digest FY2024/3 1Q(Fiscal Year Ended March 31, 2024)
（427KB）
2023/8/1
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2024
（87KB）
2023/7/14
Notice Regarding Completion of Payment for New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
（124KB）
2023/7/10
Notice Regarding Issuance of New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
（226KB）
2023/6/27
Notice regarding personnel changes
（90KB）
2023/6/19
Matters Concerning Controlling Shareholders, Etc.
（119KB）
2023/6/19
Notice regarding personnel changes
（92KB）
2023/6/17
Notice of resolutions at 77th Ordinary General Shareholders’ Meeting
（91KB）
2023/5/25
NOTICE OF 77TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
（125KB）
2023/5/12
(Corrections) Partial correction of “Notice regarding personnel changes”
（118KB）
2023/5/12
Notice regarding personnel changes
（97KB）
2023/5/12
Notice regarding changes in responsibility of directors
（95KB）
2023/5/12
Notice Regarding Company’s Propositions For 77th Ordinary General Shareholders’ Meeting
（139KB）
2023/5/1
Notice regarding introduction of entrusted Executive Officer system
（89KB）
2023/5/1
Notice Regarding Acquisition Plan of Treasury Stock
（127KB）
2023/5/1
Consolidated Financial Result Digest FY2022 Q4 (Fiscal Year Ended March 31, 2023)
（430KB）
2023/5/1
Consolidated Financial Results for the Fiscal Year Ended March 31, 2023
（813KB）
2023/4/24
Integrated Report 2022
（8,799KB）
2023/4/3
Notice of Transfer of REMINYL® (galantamine) products in Japan
（154KB）
2023/3/17
Notice regarding personnel changes
（93KB）
2023/3/17
Notice regarding revision of dividend forecast for the fiscal year ending March 2023 (including Commemorative Dividend on 70th anniversary of the company’s establishment)
（136KB）
2023/3/17
Notice of Revised Earnings Forecasts for the Fiscal Year Ending March 2023
（142KB）
2023/2/10
Consolidated Financial Result Digest FY2023 Q3 (Fiscal Year Ending March 31, 2023)
（1,141KB）
2023/2/10
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
（103KB）
2023/2/7
Notice regarding Application for Manufacturing and Marketing Approval for Half-dose formulation of Madopar® combination tablets for the treatment of Parkinsonism
（122KB）
2022/11/16
Notice regarding acquisition and acquisition completion of Treasury Stock
（127KB）
2022/11/10
Notice regarding acquisition of Treasury Stock
（125KB）
2022/11/7
Notice Regarding Disclosure of Information Based on TCFD Recommendations
（1,957KB）
2022/11/7
Consolidated Financial Result Digest FY2023/3 2Q (Fiscal Year Ending March 31, 2023)
（523KB）
2022/11/7
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2023
（171KB）
2022/10/7
Notice regarding acquisition of Treasury Stock
（125KB）
2022/9/16
Notice regarding organizational changes and personnel changes
（115KB）
2022/9/9
Annual Securities Report for the 76th business term (April 1, 2021, to March 31, 2022)
（1,083KB）
2022/9/9
Notice regarding acquisition of Treasury Stock
（126KB）
2022/8/22
Notice Regarding Completion of Payment for New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
（122KB）
2022/8/10
Notice Regarding Issuance of New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
（162KB）
2022/8/10
Notice regarding acquisition of Treasury Stock
（126KB）
2022/8/5
Notice Regarding Responses to Questions Received Upon Application to View Internet Stream
（158KB）
2022/7/27
Notice regarding personnel changes
（93KB）
2022/7/27
Consolidated Financial Result Digest FY2023/3 1Q (Fiscal Year Ending March 31, 2023)
（1,137KB）
2022/7/27
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2023
（165KB）
2022/7/8
Notice regarding acquisition of Treasury Stock
（126KB）
2022/6/20
Matters Concerning Controlling Shareholders, Etc.
（127KB）
2022/6/20
Notice regarding personnel changes
（94KB）
2022/6/20
Notice regarding Chairman of the Board of Directors
（97KB）
2022/6/20
Notice regarding changes in representative directors (Additional Appointment) and responsibility of directors
（120KB）
2022/6/18
Notice of resolutions at 76th Ordinary General Shareholders’ Meeting
（92KB）
2022/6/10
Notice regarding acquisition of Treasury Stock
（126KB）
2022/6/6
Notice Regarding Taiyo Holdings Co., Ltd.’s View of Dissenting Recommendation by Proxy Advisory Company ISS
（149KB）
2022/5/26
NOTICE OF 76TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
（270KB）
2022/5/25
NOTICE REGARDING COMPANY’S PROPOSITIONS FOR 76TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
（349KB）
2022/5/12
Notice regarding Candidate for Chairman of the Board of Directors
（109KB）
2022/5/12
Notice regarding changes in representative directors (Additional Appointment) and responsibility of directors
（119KB）
2022/5/10
Notice regarding acquisition of Treasury Stock
（126KB）
2022/4/28
Notice regarding organizational changes and personnel changes
（126KB）
2022/4/28
Notice regarding changes in responsibility of directors
（95KB）
2022/4/28
Notice regarding Director and Audit & Supervisory Board Member candidates
（105KB）
2022/4/28
Consolidated Financial Result Digest FY2022 Q4 (Fiscal Year Ended March 31, 2022)
（624KB）
2022/4/28
Notice regarding dividends from surplus
（134KB）
2022/4/28
Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
（480KB）
2022/4/8
Notice regarding acquisition of Treasury Stock
（126KB）
2022/3/18
Notice regarding organizational changes and personnel changes
（340KB）
2022/3/18
Notice regarding acquisition plan of Treasury Stock
（126KB）
2022/3/16
Integrated Report 2021
（7,579KB）
2022/2/25
Notice regarding acquisition of approval to add indications, etc. for “Kytril® injections and intravenous infusion bags” that act as 5-HT3 receptor antagonists
（176KB）
2022/2/14
Notice regarding acquisition and acquisition completion of Treasury Stock
（130KB）
2022/2/10
Notice regarding acquisition of Treasury Stock
（137KB）
2022/2/8
Consolidated Financial Result Digest FY2022 Q3 (Fiscal Year Ending March 31, 2022)
（835KB）
2022/2/8
Notice of revised forecasts for the full year of FY2022
（110KB）
2022/2/8
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2022
（266KB）
2022/1/7
Notice regarding acquisition of Treasury Stock
（136KB）
2021/12/10
Notice regarding acquisition of Treasury Stock
（137KB）
2021/12/2
Notice of Completion regarding Succession of Manufacturing and Marketing Approval for Four Long Listed Products
（121KB）
2021/11/10
Notice regarding acquisition of Treasury Stock
（136KB）
2021/11/5
Consolidated Financial Result Digest FY2022 Q2 (Fiscal Year Ending March 31, 2022)
（670KB）
2021/11/5
Notice of revised forecasts for the full year of FY2022
（101KB）
2021/11/5
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2022
（241KB）
2021/10/8
Notice regarding acquisition of Treasury Stock
（125KB）
2021/10/1
Annual Securities Report for the 75th business term (April 1, 2020, to March 31, 2021)
（968KB）
2021/9/17
Notice Regarding an Application to Select the New Market Segment, Prime Market
（85KB）
2021/9/10
Notice regarding acquisition of Treasury Stock
（108KB）
2021/8/12
Notice Regarding Compliance with Listing Maintenance Criteria for New Market Segment “Prime Market”
（112KB）
2021/8/12
Notice regarding completion of payment for issuance of additional shares of stock to provide for stock compensation system (comprising transfer-restricted stock compensation and performance-linked stock compensation)
（114KB）
2021/8/10
Notice regarding acquisition of Treasury Stock
（125KB）
2021/8/4
Notice regarding issuance of additional shares of stock to provide for stock compensation system (comprising transfer-restricted stock compensation and performance-linked stock compensation)
（244KB）
2021/8/2
Consolidated Financial Result Digest FY2022 Q1
（669KB）
2021/8/2
Notice Regarding Stock Split, Associated Partial Amendment to the Articles of Incorporation, Revision to Dividend Forecasts and Others
（171KB）
2021/8/2
Notice of Revised Forecasts for the second quarter of FY2022 and for the full year of FY2022
（235KB）
2021/8/2
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2022
（218KB）
2021/7/9
Notice regarding acquisition of Treasury Stock
（108KB）
2021/6/28
Matters Concerning Controlling Shareholders, Etc.
（123KB）
2021/6/28
Position and Policy Concerning Lowering of Trading Unit
（156KB）
2021/6/10
Briefing Material on the Long-Term Management Plan held on Monday, June 7, 2021
（1,404KB）
2021/6/10
Notice regarding acquisition of Treasury Stock
（126KB）
2021/6/4
Notice Regarding Formulation of Long-Term Management Plan
（4,208KB）
2021/5/27
NOTICE OF 75TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
（204KB）
2021/5/12
Notice of Partial Correction to “Consolidated Financial Result Digest FY2021 Q4 (Fiscal Year Ending March 31, 2021)”
（414KB）
2021/5/10
Notice regarding acquisition of Treasury Stock
（126KB）
2021/4/30
Notice regarding revision of dividend forecast for the fiscal year ending March 2021 (including Commemorative Dividend on 20th anniversary of listing)
（137KB）
2021/4/30
Consolidated Financial Result Digest FY2021 Q4 (Fiscal Year Ending March 31, 2021)
（1,652KB）
2021/4/30
Consolidated Financial Results for the Fiscal Year Ended March 31, 2021
（452KB）
2021/4/16
Notice regarding acquisition of a distribution center by our Consolidated Subsidiary
（192KB）
2021/3/29
Notice regarding organizational changes and personnel changes
（140KB）
2021/3/29
Notice regarding personnel changes
（120KB）
2021/3/23
Notice regarding acquisition and acquisition completion of Treasury Stock
（126KB）
2021/3/22
Notice regarding acquisition of Treasury Stock
（121KB）
2021/3/10
Notice regarding acquisition of Treasury Stock
（119KB）
2021/2/10
Notice regarding acquisition of Treasury Stock
（126KB）
2021/2/5
Notice regarding revision of full year earnings forecast for the fiscal year ending March 2021
（131KB）
2021/2/5
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2021
（556KB）
2021/2/5
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2021
（213KB）
2021/1/8
Notice regarding acquisition of Treasury Stock
（119KB）
2020/12/21
Notice regarding personnel changes
（112KB）
2020/12/21
Notice regarding organizational changes and personnel changes
（133KB）
2020/12/10
Notice regarding acquisition of Treasury Stock
（119KB）
2020/12/1
Notice regarding changes in the duties of directors
（104KB）
2020/12/1
Notice regarding acquisition of Treasury Stock
（110KB）
2020/12/1
Notice regarding organizational changes and personnel changes
（110KB）
2020/11/6
Notice regarding conclusion of contract with Gene Therapy Research Institution Co., Ltd. to manufacture gene therapy products
（142KB）
2020/11/6
Notice regarding revision of full year earnings forecast for the fiscal year ending March 2021
（139KB）
2020/11/6
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31,2021
（1,280KB）
2020/11/6
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2021
（243KB）
2020/10/16
Notice regarding conclusion of comprehensive partnership agreement with Cyfuse Biomedical K.K to manufacture cell products
（136KB）
2020/10/9
Notice regarding establishment of Corporate Venture Fund
（155KB）
2020/9/28
Notice regarding revision of the first half and full year earnings forecast for the fiscal year ending March 2021
（120KB）
2020/8/31
Annual Securities Report for the 74rd business term (April 1, 2019 to March 31, 2020)
（1,744KB）
2020/8/31
Notice regarding acquisition of Treasury Stock
（111KB）
2020/8/21
Results Briefing Material for Financial Results fir the First Quarterof the Fiscal Year Ending March 31,2021
（1,053KB）
2020/8/21
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2021
（211KB）
2020/8/13
Notice regarding acquisition of Treasury Stock
（108KB）
2020/8/13
Notification of the Borrowing of Funds
（114KB）
2020/8/6
Notice of Partial correction to “Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 “
（113KB）
2020/7/13
Notice regarding Business Transfer and Establishment of a New Subsidiary under our Consolidated Subsidiary
（128KB）
2020/6/15
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2020
（5,379KB）
2020/6/11
Consolidated Financial Results for the Fiscal Year Ended March 31,2020
（362KB）
2020/5/28
NOTICE OF 74RD ORDINARY GENERAL SHAREHOLDERS’ MEETING
（232KB）
2020/2/19
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31,2020
（749KB）
2020/2/19
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2020
（239KB）
2019/12/12
Annual Report 2019
（6,115KB）
2019/11/18
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31,2020
（1,999KB）
2019/11/14
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2020
（261KB）
2019/11/5
Notification of the Borrowing of Funds
（152KB）
2019/11/5
Notification of the Completion of the Acquisition of New Company Shares and Ownership of the Takatsuki Plant of Daiichi Sankyo Propharma Co., Ltd. (Subsidiary Acquisition)
（197KB）
2019/8/20
Results Briefing Material for Financial Results fir the First Quarterof the Fiscal Year Ending March 31,2020
（623KB）
2019/8/20
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2020
（254KB）
2019/8/20
Annual Securities Report for the 73rd business term (April 1, 2018 to March 31, 2019)
（2,534KB）
2019/6/14
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31,2019
（1,638KB）
2019/6/4
Notification of the Acquisition of a Long-listed Product
（117KB）
2019/6/4
Consolidated Financia Results for the Fiscal Year Ended March 31,2019
（370KB）
2019/5/30
NOTICE OF 73RD ORDINARY GENERAL SHAREHOLDERS’ MEETING
（222KB）
2019/3/25
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2019
（636KB）
2019/3/25
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2019
（240KB）
2019/3/25
Notice of Capital and Business Alliance with Cyfuse Biomedical K.K.
（77KB）
2019/3/22
Notice of Investment with Wingo Technology Co.,Ltd.
（75KB）
2019/2/14
Concerning acquisition of new company shares and ownership of Daiichi Sankyo Propharma Co., Ltd. Takatsuki Plant (subsidiary acquisition)
（154KB）
2019/1/8
Completion of Transfer of Marketing and Manufacturing Rights of 13 Long-Term Listed Products from Chugai to Taiyo Pharma
（101KB）
2018/12/4
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2019
（1,421KB）
2018/11/29
Annual Report 2018
（12,619KB）
2018/11/29
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2019
（308KB）
2018/9/5
Annual Securities Report for the 72nd business term (April 1, 2017 to March 31, 2018)
（1,047KB）
2018/8/31
Shared Research Report has been updated (Q1 FY03/19)
（2,950KB）
2018/8/16
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2019
（1,076KB）
2018/8/16
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2019
（295KB）
2018/8/8
Shared Research Flash Report has been updated (Q1 FY03/19 Flash Update)
（387KB）
2018/6/26
Shared Research Flash Report has been updated (Revision to FY03/18 Results and New Segment Information)
（141KB）
2018/6/5
NOTICE OF 72ND ORDINARY GENERAL SHAREHOLDERS’ MEETING
（204KB）
2018/5/30
Shared Research Report has been updated (Full-year FY03/18)
（2,723KB）
2018/5/22
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2018
（1,286KB）
2018/5/22
Consolidated Financial Results for the Fiscal Year Ended March 31, 2018
（392KB）
2018/3/30
Shared Research Report has been updated (concerning Notice of Revision to Dividend Forecast and A Plan to Buy Back Shares)
（152KB）
2018/2/14
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2018
（1,300KB）
2018/2/14
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2018
（352KB）
2018/1/5
Notice Concerning Execution of Asset Transfer of 13 Long-Term Listed Products from Chugai to Taiyo Pharma
（128KB）
2017/11/28
Annual Report 2017 (revised)
（8,851KB）
2017/11/28
Notice Regarding Correction to Taiyo Holdings’ Annual Report 2017
（293KB）
2017/11/20
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2018
（2,486KB）
2017/11/20
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2018
（259KB）
2017/11/14
Marketing and Manufacturing Right Transfer of 13 Long-Term Listed Products from Chugai to Taiyo Pharma
（121KB）
2017/11/14
Marketing and Manufacturing Rights Transfer of 13 Long-Term Listed Products
（186KB）
2017/8/9
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2018
（617KB）
2017/8/9
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2018
（268KB）
2017/6/15
NOTICE OF 71ST ORDINARY GENERAL SHAREHOLDERS’ MEETING
（1,358KB）
2017/6/14
Notice Concerning Formulation of Medium-Term Business Plan
（3,817KB）
2017/5/22
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2017
（1,886KB）
2017/5/22
Consolidated Financial Results for the Fiscal Year Ended March 31, 2017
（289KB）
2017/2/7
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2017
（824KB）
2017/2/7
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2017
（362KB）
2017/2/2
Notice Concerning a Capital and Business Alliance with DIC Corporation, Issuance of New Shares through a Third-party Allotment, Disposition of Treasury Shares, and Changes in Major Shareholders, the Top Shareholder among Major Shareholders, and Associated Companies.
（522KB）
2016/11/11
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2017
（836KB）
2016/11/11
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2017
（376KB）
2016/11/2
Annual Report 2016
（14,554KB）
2016/8/10
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2017
（579KB）
2016/8/10
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2017
（357KB）
2016/5/17
Consolidated Financial Results for the Fiscal Year Ending March 31, 2016
（300KB）
2016/5/17
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2016
（1,179KB）
2016/2/9
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2016
（202KB）
2016/2/9
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2016
（629KB）
2015/12/22
Annual Report 2015
（7,945KB）
2015/11/11
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2016
（98KB）
2015/11/11
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2016
（1,461KB）
2015/8/7
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2016
（180KB）
2015/8/7
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2016
（642KB）
2015/5/21
Consolidated Financial Results for the Fiscal Year Ending March 31, 2015
（336KB）
2015/5/21
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2015
（1,098KB）
2015/2/9
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2015
（200KB）
2015/2/9
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2015
（717KB）
2014/11/17
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2015
（200KB）
2014/11/17
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2015
（738KB）
2014/10/17
Annual Report 2014
（5,835KB）
2014/8/20
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2015
（204KB）
2014/8/20
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2015
（665KB）
2014/5/22
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2014
（777KB）
2014/5/22
Consolidated Financial Results for the Fiscal Year Ending March 31, 2014
（336KB）
2014/2/17
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2014
（184KB）
2014/2/17
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2014
（453KB）
2013/12/6
Annual Report 2013
（5,918KB）
2013/11/26
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2014
（190KB）
2013/11/26
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2014
（437KB）
2013/8/27
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2014
（185KB）
2013/8/27
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2014
（404KB）
2013/5/27
Consolidated Financial Results for the Fiscal Year Ending March 31, 2013
（299KB）
2013/5/27
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2013
（908KB）
2013/2/19
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2013
（185KB）
2013/2/14
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2013
（700KB）
2012/11/22
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2013
（191KB）
2012/11/22
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2013
（625KB）
2012/10/19
Annual Report 2012
（5,405KB）
2012/8/9
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2013
（197KB）
2012/8/9
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2013
（557KB）
2012/5/30
Consolidated Financial Results for the Fiscal Year Ending March 31, 2012
（335KB）
2012/5/30
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2012
（996KB）
2012/2/17
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2012
（66KB）
2012/2/17
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2012
（598KB）
2011/11/22
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2012
（720KB）
2011/11/17
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2012
（68KB）
2011/9/9
Annual Report 2011
（3,707KB）
2011/9/1
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2012
（61KB）
2011/8/9
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2012
（971KB）
2011/5/30
Consolidated Financial Results for the Fiscal Year Ended March 31, 2011
（204KB）
2011/5/30
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2011
（1,051KB）
2011/2/18
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2011
（100KB）
2011/2/18
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2011
（1,026KB）
2010/12/10
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2011
（213KB）
2010/12/10
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2011
（3,036KB）
2010/8/27
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2011
（212KB）
2010/8/27
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2011
（227KB）
2010/7/6
Notice of Transition to the Holding Company System through a Company Split and Amendments to the Articles of Incorporation. (Partial Amendment of the Corporate Name and Purpose)
（118KB）
2010/6/14
Consolidated Financial Results for the Fiscal Year Ended March 31, 2010
（162KB）
2010/6/14
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2010
（196KB）
2010/5/17
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2010
（166KB）
2010/5/17
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2010
（63KB）
2009/11/19
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2010
（165KB）
2009/11/19
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2010
（261KB）
2009/9/2
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2010
（191KB）
2009/9/2
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2010
（82KB）
2009/6/19
Consolidated Financial Results for the Fiscal Year Ended March 31, 2009
（324KB）
2009/6/19
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2009
（282KB）
2009/3/3
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2009
（179KB）
2009/3/3
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2009
（260KB）
2008/12/12
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2009
（181KB）
2008/12/12
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2009
（291KB）
2008/8/13
Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2009
（185KB）
VIEW IR NEWS
header-content
header-content
